The safety of our medicinal products is just as important as their efficacy. Drug safety is monitored through pharmacovigilance. In practice, safety information assessment is primarily based on reporting of adverse events by prescribing physicians or patients.
Reported events are collected in a global database and assessed in context with other data, and risks are analysed. The reported adverse events allow for detection of rare unexpected adverse reactions and quantitative assessment of expected adverse reactions. Safety alerts may have an impact on further use of a given medicinal product.
Please report any suspected adverse events to our products in writing to our mailbox: cz.safety@gsk.com
How to report a possible adverse event?
To help us process your information quickly and effectively, please remember to report as much relevant information as possible. Please provide the following information:
- The initials of the person who experienced the possible adverse event and/or other identifiers, such as gender, date of birth.
- The contact information of the reporter, namely the person who is reporting the issue.
- A description of the possible adverse event itself, such as the signs and symptoms experienced, date the possible adverse event started and the result of the possible side adverse event.
- The name of the GSK/ViiV product involved.
If you get any adverse events, talk to your doctor or pharmacist. This includes any possible adverse events not listed in the leaflet.
By reporting side effects you can help provide more information on the safety of this medicine. Our Privacy Notice outlines how GSK handles the processing of personal information when dealing with your enquiry, complaint or adverse event report.
Please also report to us situations of drug administration in pregnancy, overdose, abuse, medicinal product inefficacy, unexpected positive effects, possible drug interactions, misuse or off-label use and other information related to safety.
Your information will be provided to the State Institute for Drug Control* pursuant to legislation.
*By clicking on the link you will leave the GSK Czech Republic website. GlaxoSmithKline s.r.o. bears no responsibility for the following content.
